CoChat

Airborne nitric oxide: Inflammatory marker and aerocrine messenger in man

Open access
Lundberg, Jon · 1996 · Acta Physiologica Scandinavica
Cited by 83

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

1. In healthy subjects, exhaled NO originates mainly from the upper airways with only a minor contribution from the lower airways and the lungs. A large NO production takes place in the epithelium of the paranasal sinuses and this NO contributes considerably to the levels of NO found in nasally exhaled air. Immunohistochemical and mRNA in situ hybridisation studies suggest that sinus NO synthase is identical or very closely related to the human iNOS. Furthermore, the NOS activity in sinus mucosa is mostly Ca(2+)-independent. However, the regulation of sinus NOS expression seems to differ fundamentally from what has earlier been described for iNOS. Thus, sinus NOS is constitutively expressed and seems resistant to steroids. The high local NO concentrations in the nasal airways and the sinuses may help to protect against airborne infectious agents. Thus, airborne NO may represent the very first line of defence in the airways, possibly acting on pathogens even before they reach the mucosa. 2. Nasal concentrations of NO are markedly reduced in children with Kartagener's syndrome and in patients with CF. A simple chemiluminescence test test could be of help in early non-invasive diagnosis of these chronic airway diseases. 3. Inhaled endogenous NO, derived from the upper airways, may be involved in regulation of pulmonary function in man. NO will reach the lower airways and the lungs with the inspired air and at levels that are especially high during nasal breathing. This NO may act by enhancing blood flow preferentially in well ventilated areas of the lung, thus optimizing ventilation/perfusion matching. The involvement of autogenous NO in regulation of pulmonary function may represent a novel physiological principle, namely that of an enzymatically produced airborne messenger. The term "aerocrine" may be appropriate for this action of NO in the airways. These findings may also help to explain one biological role of the enigmatic human paranasal sinuses, the major sources of NO in the upper airways. 4. A continuous production of NO takes place in the acidic stomach through chemical reduction of nitrite present in swallowed saliva. This is the first evidence of non-enzymatic NO production in humans. Stomach NO may be involved in local defence against swallowed pathogens and in regulation of superficial mucosal blood flow and mucus production. 5. Luminal concentrations of NO are increased in the lower airways of asthmatic children, in the colon of patients with inflammatory bowel disease, and in the urinary bladder of patients with cystitis. Local steroid treatment reduces orally exhaled NO levels in asthmatic children. Nasal NO levels did not differ between controls and asthmatic children with or without concomitant allergic rhinitis. In conclusion, nitric oxide found in exhaled air originates mainly in the upper airways. A large production of NO takes place in the paranasal sinuses from a constitutively-expressed, steroid-resistant "inducible-like" NO synthase in the epithelial cells. Sinus NO contributes substantially to levels of NO found in nasally exhaled air. Sinus NO may have a dual function. First, the very high concentrations in the sinuses may contribute to local host defence. Second, when diluted in the inhaled air, sinus-derived NO may act as an "aerocrine" messenger, with distal effects on pulmonary blood flow and oxygen uptake. Intubated patients are deprived of autogenous NO from the upper airways and might benefit from substitution. Measurements of local NO production in hollow organs may be done easily by analysing the concentrations of NO gas in luminal air. Such noninvasive methods may be useful not only to explore the role of NO in inflammation and host defence, but also in the diagnosis and monitoring of inflammatory mucosal diseases such as asthma, ulcerative colitis and cystitis. Thus, airborne NO may be looked upon as a marker of inflammation and as an aerocrine messenger in humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apha.1996.157.s633.4

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 93

  1. 10.1126/science.1084576 · DOI · Paper page
  2. 10.1111/j.1476-5381.1993.tb13874.x · DOI
  3. 10.1111/j.1748-1716.1991.tb09056.x · doi:10.1111/j.1748-1716.1991.tb09056.x
  4. 10.1096/fasebj.7.2.8440411 · DOI · Paper page
  5. 10.1073/pnas.74.8.3203 · DOI · Paper page
  6. 10.1073/pnas.91.21.10089 · DOI · Paper page
  7. 10.1073/pnas.87.4.1620 · DOI · Paper page
  8. 10.1097/00000542-199404000-00007 · doi:10.1097/00000542-199404000-00007
  9. 10.1016/S1053-0770(05)80242-3 · DOI
  10. 10.1136/thx.48.11.1160 · DOI
  11. 10.1016/0140-6736(93)91476-3 · DOI · Paper page
  12. 10.1016/0014-2999(90)94185-Z · DOI
  13. 10.1038/347768a0 · DOI · Paper page
  14. 10.1016/0014-2999(92)90824-N · DOI · Paper page
  15. Chung S., 1990, Identification of the subcellular site for nitroglycerine metabolism to nitric oxide in bovine coronary smooth muscle cells, J Pharmacol Exp Ther, 253, 614, 10.1016/S0022-3565(25)13024-3 · DOI · Paper page
  16. 10.1172/JCI116479 · DOI · Paper page
  17. 10.1007/BF00716936 · DOI · Paper page
  18. 10.1007/BF00297196 · DOI
  19. 10.1161/01.CIR.83.6.2038 · DOI · Paper page
  20. 10.1038/288373a0 · DOI · Paper page
  21. 10.1164/ajrccm.153.2.8564142 · DOI
  22. 10.1161/01.CIR.93.2.318 · DOI
  23. 10.1073/pnas.90.8.3491 · DOI · Paper page
  24. 10.1016/S0140-6736(94)91465-6 · DOI · Paper page
  25. 10.1097/00000658-199306000-00006 · DOI · Paper page
  26. 10.1113/jphysiol.1957.sp005777 · DOI · Paper page
  27. 10.1016/S0140-6736(05)80083-2 · DOI · Paper page
  28. 10.1016/0009-8981(82)90187-5 · DOI · Paper page
  29. 10.1007/BF00183275 · DOI · Paper page
  30. 10.1016/S0006-291X(88)80015-9 · DOI · Paper page
  31. Hibbs J.B., 1987, L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells, J Immunol, 138, 550, 10.4049/jimmunol.138.2.550 · DOI · Paper page
  32. 10.1016/0092-8674(93)90615-W · DOI · Paper page
  33. 10.1016/0140-6736(93)90802-N · DOI · Paper page
  34. 10.1111/j.1476-5381.1993.tb13868.x · DOI · Paper page
  35. 10.1146/annurev.pa.30.040190.002535 · DOI · Paper page
  36. Ignarro L.J., 1991, Heme-dependent activation of guanylate cyclase by nitric oxide: a novel signal transduction mechanism, Blood Vessels, 28, 67
  37. 10.1073/pnas.84.24.9265 · DOI · Paper page
  38. 10.1007/BF00698741 · doi:10.1007/bf00698741
  39. 10.1111/j.1365-2249.1995.tb05560.x · DOI · Paper page
  40. 10.1006/bbrc.1993.1187 · DOI · Paper page
  41. Ji X., 1989, Nitrate reductase of Escherichia coli as a NO-producing nitrite reductase, Biochem Arch, 5, 61
  42. 10.1016/S0140-6736(94)90931-8 · DOI · Paper page
  43. 10.1164/ajrccm.151.6.7767537 · DOI · Paper page
  44. 10.1164/ajrccm.151.6.7767536 · DOI · Paper page
  45. 10.1183/09031936.95.08020295 · DOI · Paper page
  46. 10.1164/ajrccm.153.6.8665033 · DOI · Paper page
  47. Kitagawa H., 1990, Effect of endothelium derived relaxing factor on gastric lesion Induced by HC1 in Rats, J Pharmacol Exp Ther, 253, 1133, 10.1016/S0022-3565(25)13213-8 · DOI · Paper page
  48. 10.1016/0006-291X(90)91551-3 · DOI · Paper page
  49. 10.1073/pnas.88.11.4651 · DOI · Paper page
  50. 10.1378/chest.99.6.1352 · doi:10.1378/chest.99.6.1352
  51. 10.1016/1043-2760(94)90105-8 · DOI
  52. 10.1111/j.1476-5381.1994.tb14887.x · DOI · Paper page
  53. 10.1006/bbrc.1994.1784 · DOI
  54. Lepoivre M., 1992, Early loss of the tyrosyl radical in ribonucleotide reductase of adenocarcinoma cells producing nitric oxide, J Biol Chem, 267, 2994, 10.1016/S0021-9258(18)50046-6 · DOI
  55. Levison H., 1983, Pathophysiology of the ciliary motility syndromes, Eur J Resp Dis, 64, 102
  56. 10.1016/0304-3940(93)90280-X · DOI
  57. Lundberg J.O.N., 1995, Nitric oxide in ulcerative colitis, Lancet, 345, 449
  58. 10.1111/j.1748-1716.1995.tb09998.x · DOI
  59. 10.1128/aem.46.1.198-202.1983 · DOI · Paper page
  60. 10.1021/bi00424a003 · DOI · Paper page
  61. Marsden P.A., 1993, Structure and chromosomal localisation of the human constitutive endothelial nitric oxide synthase, J Biol Chem, 268, 17478, 10.1016/S0021-9258(19)85359-0 · DOI · Paper page
  62. 10.1111/j.1476-5381.1993.tb13478.x · doi:10.1111/j.1476-5381.1993.tb13478.x
  63. 10.1164/ajrccm.152.2.7633745 · DOI · Paper page
  64. 10.1111/j.1365-2362.1993.tb01292.x · DOI · Paper page
  65. 10.1016/0140-6736(93)90211-X · DOI · Paper page
  66. Miller M.J.S., 1993, Amelioration of chronic ileitis by nitric oxide synthase inhibition, J Pharmacol Exp Ther, 264, 11, 10.1016/S0022-3565(25)10238-3 · DOI · Paper page
  67. 10.1056/NEJM199312303292706 · DOI · Paper page
  68. Moncada S., 1991, Nitric oxide: Physiology, pathophysiology, and pharmacology, Pharmacol Rev, 43, 109, 10.1016/S0031-6997(25)06663-3 · DOI · Paper page
  69. Murad F., 1978, Guanylate cyclase: activation by azide, nitro compounds, nitric oxide and hydroxyl radical and inhibition by hemoglobine and myoglobin, Adv Cyclic Nucleotide Res, 9, 145
  70. 10.1006/bbrc.1995.1003 · DOI · Paper page
  71. 10.1016/0014-5793(93)81210-Q · DOI · Paper page
  72. 10.1096/fasebj.6.12.1381691 · DOI · Paper page
  73. 10.1016/0092-8674(94)90266-6 · DOI · Paper page
  74. Nussler A.K., 1993, Inflammation, immunoregulation, and inducible nitric oxide synthase, J Leuk Biology, 54, 171, 10.1002/jlb.54.2.171 · DOI · Paper page
  75. 10.1038/327524a0 · DOI · Paper page
  76. 10.1164/ajrccm/148.5.1210 · DOI · Paper page
  77. 10.1007/BF01720903 · DOI · Paper page
  78. 10.1136/gut.36.5.718 · DOI · Paper page
  79. 10.1016/S0140-6736(95)90427-1 · DOI
  80. 10.1056/NEJM199302113280605 · DOI · Paper page
  81. 10.1378/chest.107.4.1107 · doi:10.1378/chest.107.4.1107
  82. Rubbot H., 1994, Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation, J Biol Chem, 269, 26066, 10.1016/S0021-9258(18)47160-8 · DOI · Paper page
  83. 10.1073/pnas.90.15.7240 · DOI · Paper page
  84. Salzman A.L., 1995, Nitric oxide in the gut, New Horizons, 3, 33
  85. 10.3109/10715769009149890 · DOI · Paper page
  86. 10.1172/JCI117585 · DOI · Paper page
  87. 10.1111/j.1365-2125.1976.tb00609.x · DOI
  88. Tepperman B.L., 1993, Nitric oxide synthase induction and intestinal epithelial cell viability in rats, Am J, 265, G214
  89. 10.1111/j.1748-1716.1994.tb09733.x · DOI
  90. 10.1073/pnas.92.17.7804 · DOI · Paper page
  91. 10.1111/j.1748-1716.1991.tb09259.x · DOI
  92. Whittle B.J.R., 1994, Physiology of the gastrointestinal tract, 267
  93. 10.1006/bbrc.1995.1993 · doi:10.1006/bbrc.1995.1993

Cited by

See all 83

Metadata

Authors
Lundberg, J.
Venue
Acta Physiologica Scandinavica
Publisher
Wiley
Published
1996-06
Volume
157
Issue
S633
Pages
4-27
ISSN
  • 0001-6772 (ISSN-L)
  • 1365-201X
OpenAlex
W100799147
Cited by
83
References
12
FWCI
4.01
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Airborne nitric oxide: Inflammatory marker and aerocrine messenger in man. https://app.cochat.ai/papers/10.1111/apha.1996.157.s633.4
The paper
Lundberg, J. (1996). Airborne nitric oxide: Inflammatory marker and aerocrine messenger in man. Acta Physiologica Scandinavica. https://doi.org/10.1111/apha.1996.157.s633.4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.